<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36639608</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1740-1534</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Nature reviews. Microbiology</Title><ISOAbbreviation>Nat Rev Microbiol</ISOAbbreviation></Journal><ArticleTitle>Long COVID: major findings, mechanisms and recommendations.</ArticleTitle><Pagination><StartPage>133</StartPage><EndPage>146</EndPage><MedlinePgn>133-146</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41579-022-00846-2</ELocationID><Abstract><AbstractText>Long COVID is an often debilitating illness that occurs in at least 10% of severe acute respiratory syndrome coronavirus&#xa0;2 (SARS-CoV-2) infections. More than 200 symptoms have been identified with impacts on multiple organ systems. At least 65 million individuals worldwide are estimated to have long COVID, with cases increasing daily. Biomedical research has made substantial progress in identifying various pathophysiological changes and risk factors and in characterizing the illness; further, similarities with other viral-onset illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachycardia syndrome have laid the groundwork for research in the field. In this Review, we explore the current literature and highlight key findings, the overlap with other conditions, the variable onset of symptoms, long COVID in children and the impact of vaccinations. Although these key findings are critical to understanding long COVID, current diagnostic and treatment options are insufficient, and clinical trials must be prioritized that address leading hypotheses. Additionally, to strengthen long COVID research, future studies must account for biases and SARS-CoV-2 testing issues, build on viral-onset research, be inclusive of marginalized populations and meaningfully engage patients throughout the research process.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Hannah E</ForeName><Initials>HE</Initials><Identifier Source="ORCID">0000-0002-1245-2034</Identifier><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCorkell</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3261-6737</Identifier><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vogel</LastName><ForeName>Julia Moore</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-4902-3540</Identifier><AffiliationInfo><Affiliation>Scripps Research Translational Institute, Scripps Research, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Topol</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-1478-4729</Identifier><AffiliationInfo><Affiliation>Scripps Research Translational Institute, Scripps Research, La Jolla, CA, USA. etopol@scripps.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002550</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Microbiol</MedlineTA><NlmUniqueID>101190261</NlmUniqueID><ISSNLinking>1740-1526</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Rev Microbiol. 2023 Jun;21(6):408. doi: 10.1038/s41579-023-00896-0</RefSource><PMID Version="1">37069455</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pii">10.1038/s41579-022-00846-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ballering AV, van Zon SKR, Hartman TCO, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L. Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years &#x2014; United States, March 2020&#x2013;November 2021. MMWR Morb. Mortal. Wkly Rep. 2022;71:713. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022 doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani, D. et al. Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study. Preprint at medRxiv10.1101/2022.02.23.22271388 (2022).</Citation></Reference><Reference><Citation>FAIR Health. Patients Diagnosed with Post-COVID Conditions: An Analysis of Private Healthcare Claims Using the Official ICD-10 Diagnostic Code (FAIR Health, 2022).</Citation></Reference><Reference><Citation>Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini DM, et al. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post&#x2013;coronavirus disease. JACC Heart Fail. 2021;9:927&#x2013;937. doi: 10.1016/j.jchf.2021.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 2022;13:5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen NW, et al. Characterization of autonomic symptom burden in long COVID: a global survey of 2314 adults. Front. Neurol. 2022;13:1012668. doi: 10.3389/fneur.2022.1012668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1012668</ArticleId><ArticleId IdType="pmc">PMC9639503</ArticleId><ArticleId IdType="pubmed">36353127</ArticleId></ArticleIdList></Reference><Reference><Citation>Demko, Z. O. et al. Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection. Preprint at medRxiv10.1101/2022.08.08.22278543 (2022).</Citation></Reference><Reference><Citation>Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup. Med. Oxf. Engl. 2005;55:20&#x2013;31. doi: 10.1093/occmed/kqi013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqi013</ArticleId><ArticleId IdType="pubmed">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach, K. Is &#x2018;long Covid&#x2019; worsening the labor shortage? Brookingshttps://www.brookings.edu/research/is-long-covid-worsening-the-labor-shortage/ (2022).</Citation></Reference><Reference><Citation>Swank Z, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 2022 doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, J. et al. Distinguishing features of Long COVID identified through immune profiling. Preprint at medRxiv10.1101/2022.08.09.22278592 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S, Kril I, Nadizhko O, Matsyura O, Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol. Int. 2022 doi: 10.1007/s00296-022-05146-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Evidence of recent Epstein-Barr virus reactivation in individuals experiencing Long COVID. Preprint at medRxiv. 2022 doi: 10.1101/2022.06.21.22276660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.21.22276660</ArticleId><ArticleId IdType="pmc">PMC9753782</ArticleId><ArticleId IdType="pubmed">36523412</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes de Almeida V. Gut microbiota from patients with mild COVID-19 cause alterations in mice that resemble post-COVID syndrome. Res. Sq. 2022 doi: 10.21203/rs.3.rs-1756189/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1756189/v1</ArticleId><ArticleId IdType="pmc">PMC10481883</ArticleId><ArticleId IdType="pubmed">37668317</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J. Transl Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur JM, et al. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J. Transl Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front. Cardiovasc. Med. 2021 doi: 10.3389/fcvm.2021.745758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/post-acute sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz-Polster H, Tremblay M-E, Bienzle D, Fischer JE. The pathobiology of myalgic encephalomyelitis/chronic fatigue syndrome: the case for neuroglial failure. Front. Cell. Neurosci. 2022;16:888232. doi: 10.3389/fncel.2022.888232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.888232</ArticleId><ArticleId IdType="pmc">PMC9124899</ArticleId><ArticleId IdType="pubmed">35614970</ArticleId></ArticleIdList></Reference><Reference><Citation>Merzon E, et al. Clinical and socio-demographic variables associated with the diagnosis of long COVID syndrome in youth: a population-based study. Int. J. Environ. Res. Public Health. 2022;19:5993. doi: 10.3390/ijerph19105993.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19105993</ArticleId><ArticleId IdType="pmc">PMC9141083</ArticleId><ArticleId IdType="pubmed">35627530</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Long COVID - household pulse survey - COVID-19. CDChttps://www.cdc.gov/nchs/covid19/pulse/long-covid.htm (2022).</Citation></Reference><Reference><Citation>Williamson AE, Tydeman F, Miners A, Pyper K, Martineau AR. Short-term and long-term impacts of COVID-19 on economic vulnerability: a population-based longitudinal study (COVIDENCE UK) BMJ Open. 2022;12:e065083. doi: 10.1136/bmjopen-2022-065083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-065083</ArticleId><ArticleId IdType="pmc">PMC9402446</ArticleId><ArticleId IdType="pubmed">35998959</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N, et al. Characteristics and impact of Long Covid: findings from an online survey. PLoS ONE. 2022;17:e0264331. doi: 10.1371/journal.pone.0264331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat. Med. 2022;28:911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med. 2021;27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, et al. From online data collection to identification of disease mechanisms: the IL-1&#xdf;, IL-6 and TNF-&#x3b1; cytokine triad is associated with post-acute sequelae of COVID-19 in a digital research cohort. SSRN. 2021 doi: 10.2139/ssrn.3963839.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3963839</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv. 2022 doi: 10.1101/2022.01.07.475453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId><ArticleId IdType="pmc">PMC8764721</ArticleId><ArticleId IdType="pubmed">35043113</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, et al. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci. Adv. 2015;1:e1400121. doi: 10.1126/sciadv.1400121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1400121</ArticleId><ArticleId IdType="pmc">PMC4465185</ArticleId><ArticleId IdType="pubmed">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E, et al. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic &#x435;ncephalomyelitis/chronic fatigue syndrome. J. Med. Virol. 2020;92:3682&#x2013;3688. doi: 10.1002/jmv.25744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25744</ArticleId><ArticleId IdType="pmc">PMC7687071</ArticleId><ArticleId IdType="pubmed">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiner P, et al. Human herpesvirus-6 reactivation, mitochondrial fragmentation, and the coordination of antiviral and metabolic phenotypes in myalgic encephalomyelitis/chronic fatigue syndrome. Immunohorizons. 2020;4:201&#x2013;215. doi: 10.4049/immunohorizons.2000006.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.2000006</ArticleId><ArticleId IdType="pubmed">32327453</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J, et al. Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study. J. Clin. Immunol. 2021;41:1490&#x2013;1501. doi: 10.1007/s10875-021-01083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01083-7</ArticleId><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A, et al. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. bioRxiv. 2022 doi: 10.1101/2021.05.26.442666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.26.442666</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, et al. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell. Mol. Immunol. 2020;17:1119&#x2013;1125. doi: 10.1038/s41423-020-00550-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00550-2</ArticleId><ArticleId IdType="pmc">PMC7546387</ArticleId><ArticleId IdType="pubmed">33037400</ArticleId></ArticleIdList></Reference><Reference><Citation>Korte W, et al. SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on. J. Infect. 2021;82:e11&#x2013;e14. doi: 10.1016/j.jinf.2020.08.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.032</ArticleId><ArticleId IdType="pmc">PMC7445467</ArticleId><ArticleId IdType="pubmed">32853597</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo W, et al. A two-phase, single cohort study of COVID-19 antibody sera-surveillance. Ann. Epidemiol. Public Health. 2021;4:1055. doi: 10.33582/2639-4391/1055.</Citation><ArticleIdList><ArticleId IdType="doi">10.33582/2639-4391/1055</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura Y, et al. Attenuation of antibody titers from 3 to 6 months after the second dose of the BNT162b2 vaccine depends on sex, with age and smoking risk factors for lower antibody titers at 6 months. Vaccines. 2021;9:1500. doi: 10.3390/vaccines9121500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9121500</ArticleId><ArticleId IdType="pmc">PMC8708461</ArticleId><ArticleId IdType="pubmed">34960246</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 2022;22:211. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh, D. et al. Persistence of residual SARS-CoV-2 viral antigen and RNA in tissues of patients with long COVID-19. Preprint at https://www.researchsquare.com/article/rs-1379777/v1 (2022).</Citation></Reference><Reference><Citation>Ceulemans LJ, et al. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19. Lancet Respir. Med. 2021;9:e78&#x2013;e79. doi: 10.1016/S2213-2600(21)00240-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00240-X</ArticleId><ArticleId IdType="pmc">PMC8189667</ArticleId><ArticleId IdType="pubmed">34118186</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Menuchin-Lasowski Y, et al. SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids. Stem Cell Rep. 2022;17:789&#x2013;803. doi: 10.1016/j.stemcr.2022.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.02.015</ArticleId><ArticleId IdType="pmc">PMC8943915</ArticleId><ArticleId IdType="pubmed">35334213</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71:226&#x2013;229. doi: 10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3:371&#x2013;387.e9. doi: 10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ. 2022;377:e069590. doi: 10.1136/bmj-2021-069590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069590</ArticleId><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, et al. Persistent clotting protein pathology in Long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kub&#xe1;nkov&#xe1; M, et al. Physical phenotype of blood cells is altered in COVID-19. Biophys. J. 2021;120:2838&#x2013;2847. doi: 10.1016/j.bpj.2021.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.05.025</ArticleId><ArticleId IdType="pmc">PMC8169220</ArticleId><ArticleId IdType="pubmed">34087216</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I, et al. Persistent capillary rarefication in long COVID syndrome. Angiogenesis. 2022 doi: 10.1007/s10456-022-09850-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MA, et al. Elevated vascular transformation blood biomarkers in long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol. Med. 2022;28:122. doi: 10.1186/s10020-022-00548-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00548-8</ArticleId><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Fern&#xe1;ndez A, et al. Cardiac impairment in Long Covid 1-year post-SARS-CoV-2 infection. Eur. Heart J. 2022;43:ehac544.219. doi: 10.1093/eurheartj/ehac544.219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac544.219</ArticleId><ArticleId IdType="pmc">PMC9950586</ArticleId><ArticleId IdType="pubmed">36822818</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11:e048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis, A. et al. Multi-organ impairment and Long COVID: a 1-year prospective, longitudinal cohort study. Preprint at medRxiv10.1101/2022.03.18.22272607 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in Long COVID. J. Am. Soc. Nephrol. 2021;32:2851&#x2013;2862. doi: 10.1681/ASN.2021060734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Almufarrij I, Munro KJ. One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms. Int. J. Audiol. 2021;60:935&#x2013;945. doi: 10.1080/14992027.2021.1896793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14992027.2021.1896793</ArticleId><ArticleId IdType="pubmed">33750252</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdsworth DA, et al. Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID. PLoS ONE. 2022;17:e0267392. doi: 10.1371/journal.pone.0267392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0267392</ArticleId><ArticleId IdType="pmc">PMC9187094</ArticleId><ArticleId IdType="pubmed">35687603</ArticleId></ArticleIdList></Reference><Reference><Citation>Cysique, L. A. et al. Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study. Preprint at medRxiv10.1101/2022.06.07.22276020 (2022).</Citation></Reference><Reference><Citation>Crivelli L, et al. Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement. 2022;18:1047&#x2013;1066. doi: 10.1002/alz.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo MS, et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2:fcaa205. doi: 10.1093/braincomms/fcaa205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa205</ArticleId><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiken S, et al. Alzheimer&#x2019;s-like signaling in brains of COVID-19 patients. Alzheimers Dement. 2022;18:955&#x2013;965. doi: 10.1002/alz.12558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12558</ArticleId><ArticleId IdType="pmc">PMC9011576</ArticleId><ArticleId IdType="pubmed">35112786</ArticleId></ArticleIdList></Reference><Reference><Citation>Charnley M, et al. Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19. Nat. Commun. 2022;13:3387. doi: 10.1038/s41467-022-30932-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30932-1</ArticleId><ArticleId IdType="pmc">PMC9189797</ArticleId><ArticleId IdType="pubmed">35697699</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser, D. et al. Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET. Preprint at medRxiv10.1101/2022.06.02.22275916 (2022).</Citation></Reference><Reference><Citation>Guedj E, et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, et al. Cognitive decline and brainstem hypometabolism in long COVID: a case series. Brain Behav. 2022;12:e2513. doi: 10.1002/brb3.2513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2513</ArticleId><ArticleId IdType="pmc">PMC9014998</ArticleId><ArticleId IdType="pubmed">35290729</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple AC, et al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann. Clin. Transl Neurol. 2022;9:221&#x2013;226. doi: 10.1002/acn3.51498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51498</ArticleId><ArticleId IdType="pmc">PMC8862406</ArticleId><ArticleId IdType="pubmed">35043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann. Neurol. 2022;91:772&#x2013;781. doi: 10.1002/ana.26350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Villaume WA. Marginal BH4 deficiencies, iNOS, and self-perpetuating oxidative stress in post-acute sequelae of Covid-19. Med. Hypotheses. 2022;163:110842. doi: 10.1016/j.mehy.2022.110842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2022.110842</ArticleId><ArticleId IdType="pmc">PMC9006446</ArticleId><ArticleId IdType="pubmed">35431403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitirgen G, et al. Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID. Br. J. Ophthalmol. 2021 doi: 10.1136/bjophthalmol-2021-319450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2021-319450</ArticleId><ArticleId IdType="pmc">PMC8359871</ArticleId><ArticleId IdType="pubmed">34312122</ArticleId></ArticleIdList></Reference><Reference><Citation>Barros A, et al. Small fiber neuropathy in the cornea of Covid-19 patients associated with the generation of ocular surface disease. Ocul. Surf. 2022;23:40&#x2013;48. doi: 10.1016/j.jtos.2021.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtos.2021.10.010</ArticleId><ArticleId IdType="pmc">PMC8588585</ArticleId><ArticleId IdType="pubmed">34781021</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitirgen G, et al. Abnormal quantitative pupillary light responses following COVID-19. Int. Ophthalmol. 2022 doi: 10.1007/s10792-022-02275-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-022-02275-9</ArticleId><ArticleId IdType="pmc">PMC8980787</ArticleId><ArticleId IdType="pubmed">35380318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mardin CY, et al. Possible impact of functional active GPCR-autoantibodies on retinal microcirculation in long-COVID. Invest. Ophthalmol. Vis. Sci. 2022;63:3315&#x2013;F0124.</Citation></Reference><Reference><Citation>Zhang B-Z, et al. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 2020;30:928&#x2013;931. doi: 10.1038/s41422-020-0390-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0390-x</ArticleId><ArticleId IdType="pmc">PMC7399356</ArticleId><ArticleId IdType="pubmed">32753756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S, et al. Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review. Int. Ophthalmol. 2022;42:323&#x2013;336. doi: 10.1007/s10792-021-01996-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-021-01996-7</ArticleId><ArticleId IdType="pmc">PMC8356207</ArticleId><ArticleId IdType="pubmed">34379290</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery. Sci. Transl Med. 2022;14:eabq3059. doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat. Commun. 2022;13:1745. doi: 10.1038/s41467-022-29440-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of Select Populations, &amp; Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness (National Academies Press, 2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin. Proc. 2021;96:2861&#x2013;2878. doi: 10.1016/j.mayocp.2021.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>The ME Association. Index of ME/CFS published research - Nov 2022. 224 Index of ME/CFS Published Research. The ME Associationhttps://meassociation.org.uk/ (2022).</Citation></Reference><Reference><Citation>Seltzer, J. &amp; Thomas, J. ME Research Summary 2019 (The ME Association, 2019).</Citation></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Med. (Kaunas.) 2021;57:418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R, et al. Chronic fatigue and postexertional malaise in people living with Long COVID: an observational study. Phys. Ther. 2022;102:pzac005. doi: 10.1093/ptj/pzac005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, et al. Orthostatic challenge causes distinctive symptomatic, hemodynamic and cognitive responses in Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. Front. Med. 2022;9:917019. doi: 10.3389/fmed.2022.917019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.917019</ArticleId><ArticleId IdType="pmc">PMC9285104</ArticleId><ArticleId IdType="pubmed">35847821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH-B, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch. Intern. Med. 2009;169:2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller BA, Pryor JL, Giloteaux L. Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment. J. Transl Med. 2014;12:104. doi: 10.1186/1479-5876-12-104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-12-104</ArticleId><ArticleId IdType="pmc">PMC4004422</ArticleId><ArticleId IdType="pubmed">24755065</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha AK, et al. Erythrocyte deformability as a potential biomarker for chronic fatigue syndrome. Blood. 2018;132:4874. doi: 10.1182/blood-2018-99-117260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-99-117260</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Resendiz KJG, et al. Loss of mitochondrial membrane potential (&#x394;&#x3a8;m) in leucocytes as post-COVID-19 sequelae. J. Leukoc. Biol. 2022;112:23&#x2013;29. doi: 10.1002/JLB.3MA0322-279RRR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3MA0322-279RRR</ArticleId><ArticleId IdType="pmc">PMC9088601</ArticleId><ArticleId IdType="pubmed">35355308</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi A. COVID-19 and mitochondrial non-coding RNAs: new insights from published data. Front. Physiol. 2022;12:805005. doi: 10.3389/fphys.2021.805005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.805005</ArticleId><ArticleId IdType="pmc">PMC8856670</ArticleId><ArticleId IdType="pubmed">35185603</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur VP, et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC) Metabolites. 2022;12:1026. doi: 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Astill SL, Sivan M. The relationship between physical activity and Long COVID: a cross-sectional study. Int. J. Environ. Res. Public Health. 2022;19:5093. doi: 10.3390/ijerph19095093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095093</ArticleId><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Heerdt PM, Shelley B, Singh I. Impaired systemic oxygen extraction long after mild COVID-19: potential perioperative implications. Br. J. Anaesth. 2022;128:e246&#x2013;e249. doi: 10.1016/j.bja.2021.12.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.12.036</ArticleId><ArticleId IdType="pmc">PMC8710396</ArticleId><ArticleId IdType="pubmed">35067364</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, et al. Multisystem involvement in post-acute sequelae of coronavirus disease 19. Ann. Neurol. 2022;91:367&#x2013;379. doi: 10.1002/ana.26286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26286</ArticleId><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E, et al. Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome. J. Proteome Res. 2021;20:3315&#x2013;3329. doi: 10.1021/acs.jproteome.1c00224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CLMC, Visser FC. Orthostatic intolerance in long-haul COVID after SARS-CoV-2: a case-control comparison with post-EBV and insidious-onset myalgic encephalomyelitis/chronic fatigue syndrome patients. Healthcare. 2022;10:2058. doi: 10.3390/healthcare10102058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10102058</ArticleId><ArticleId IdType="pmc">PMC9602265</ArticleId><ArticleId IdType="pubmed">36292504</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CLMC, Visser FC. Long-Haul COVID patients: prevalence of POTS are reduced but cerebral blood flow abnormalities remain abnormal with longer disease duration. Healthcare. 2022;10:2105. doi: 10.3390/healthcare10102105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10102105</ArticleId><ArticleId IdType="pmc">PMC9602558</ArticleId><ArticleId IdType="pubmed">36292552</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes JM, Kruger A, Proal A, Kell DB, Pretorius E. The occurrence of hyperactivated platelets and fibrinaloid microclots in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Pharmaceuticals. 2022;15:931. doi: 10.3390/ph15080931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15080931</ArticleId><ArticleId IdType="pmc">PMC9413879</ArticleId><ArticleId IdType="pubmed">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM. 2008;101:961&#x2013;965. doi: 10.1093/qjmed/hcn123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcn123</ArticleId><ArticleId IdType="pubmed">18805903</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BH, et al. The face of postural tachycardia syndrome &#x2013; insights from a large cross&#x2010;sectional online community&#x2010;based survey. J. Intern. Med. 2019;286:438&#x2013;448. doi: 10.1111/joim.12895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12895</ArticleId><ArticleId IdType="pmc">PMC6790699</ArticleId><ArticleId IdType="pubmed">30861229</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, et al. Postural orthostatic tachycardia syndrome (POTS): priorities for POTS care and research from a 2019 National Institutes of Health expert consensus meeting - part 2. Auton. Neurosci. Basic. Clin. 2021;235:102836. doi: 10.1016/j.autneu.2021.102836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102836</ArticleId><ArticleId IdType="pmc">PMC8455430</ArticleId><ArticleId IdType="pubmed">34246578</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, et al. Peripheral neuropathy evaluations of patients with prolonged Long COVID. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1146. doi: 10.1212/NXI.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen NW, et al. Characterization of autonomic symptom burden in long COVID: a global survey of 2,314 adults. Front. Neurol. 2022;13:1012668. doi: 10.3389/fneur.2022.1012668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1012668</ArticleId><ArticleId IdType="pmc">PMC9639503</ArticleId><ArticleId IdType="pubmed">36353127</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, et al. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Boneva RS, et al. Endometriosis as a comorbid condition in chronic fatigue syndrome (CFS): secondary analysis of data from a CFS case-control study. Front. Pediatr. 2019;7:195. doi: 10.3389/fped.2019.00195.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00195</ArticleId><ArticleId IdType="pmc">PMC6537603</ArticleId><ArticleId IdType="pubmed">31179251</ArticleId></ArticleIdList></Reference><Reference><Citation>Brag&#xe9;e, B. et al. Signs of intracranial hypertension, hypermobility, and craniocervical obstructions in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front. Neurol. 11, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7485557</ArticleId><ArticleId IdType="pubmed">32982905</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina-Perucha L, et al. Self-reported menstrual alterations during the COVID-19 syndemic in Spain: a cross-sectional study. Int. J. Womens Health. 2022;14:529&#x2013;544. doi: 10.2147/IJWH.S354655.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJWH.S354655</ArticleId><ArticleId IdType="pmc">PMC9013667</ArticleId><ArticleId IdType="pubmed">35444473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding T, et al. Analysis of ovarian injury associated with COVID-19 disease in reproductive-aged women in Wuhan, China: an observational study. Front. Med. 2021;8:635255. doi: 10.3389/fmed.2021.635255.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.635255</ArticleId><ArticleId IdType="pmc">PMC8017139</ArticleId><ArticleId IdType="pubmed">33816526</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp GC, et al. The COVID-19 pandemic and the menstrual cycle: research gaps and opportunities. Int. J. Epidemiol. 2021 doi: 10.1093/ije/dyab239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab239</ArticleId><ArticleId IdType="pmc">PMC8690231</ArticleId><ArticleId IdType="pubmed">34865021</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SM, et al. SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT study. Am. J. Obstet. Gynecol. 2022;226:270&#x2013;273. doi: 10.1016/j.ajog.2021.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.09.016</ArticleId><ArticleId IdType="pmc">PMC8452349</ArticleId><ArticleId IdType="pubmed">34555320</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlow BL, Signorello LB, Hall JE, Dailey C, Komaroff AL. Reproductive correlates of chronic fatigue syndrome. Am. J. Med. 1998;105:94S&#x2013;99S. doi: 10.1016/S0002-9343(98)00173-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(98)00173-9</ArticleId><ArticleId IdType="pubmed">9790489</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas N, Gurvich C, Huang K, Gooley PR, Armstrong CW. The underlying sex differences in neuroendocrine adaptations relevant to myalgic encephalomyelitis chronic fatigue syndrome. Front. Neuroendocrinol. 2022;66:100995. doi: 10.1016/j.yfrne.2022.100995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2022.100995</ArticleId><ArticleId IdType="pubmed">35421511</ArticleId></ArticleIdList></Reference><Reference><Citation>Boneva RS, Lin J-MS, Unger ER. Early menopause and other gynecologic risk indicators for chronic fatigue syndrome in women. Menopause. 2015;22:826&#x2013;834. doi: 10.1097/GME.0000000000000411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GME.0000000000000411</ArticleId><ArticleId IdType="pmc">PMC5745581</ArticleId><ArticleId IdType="pubmed">25647777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kresch E, et al. COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis. World J. Mens Health. 2021;39:466&#x2013;469. doi: 10.5534/wjmh.210055.</Citation><ArticleIdList><ArticleId IdType="doi">10.5534/wjmh.210055</ArticleId><ArticleId IdType="pmc">PMC8255400</ArticleId><ArticleId IdType="pubmed">33988001</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleki BH, Tartibian B. COVID-19 and male reproductive function: a prospective, longitudinal cohort study. Reproduction. 2021;161:319&#x2013;331. doi: 10.1530/REP-20-0382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/REP-20-0382</ArticleId><ArticleId IdType="pubmed">33522983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu JZ, et al. Lung perfusion disturbances in nonhospitalized post-COVID with dyspnea &#x2014; a magnetic resonance imaging feasibility study. J. Intern. Med. 2022;292:941&#x2013;956. doi: 10.1111/joim.13558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13558</ArticleId><ArticleId IdType="pmc">PMC9539011</ArticleId><ArticleId IdType="pubmed">35946904</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JL, et al. Quantitative chest CT assessment of small airways disease in post-acute SARS-CoV-2 infection. Radiology. 2022;304:185&#x2013;192. doi: 10.1148/radiol.212170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.212170</ArticleId><ArticleId IdType="pmc">PMC9270680</ArticleId><ArticleId IdType="pubmed">35289657</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity. 2022;55:542&#x2013;556.e5. doi: 10.1016/j.immuni.2022.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield KM, et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLOS Pathog. 2022;18:e1010359. doi: 10.1371/journal.ppat.1010359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Meringer H, Mehandru S. Gastrointestinal post-acute COVID-19 syndrome. Nat. Rev. Gastroenterol. Hepatol. 2022;19:345&#x2013;346. doi: 10.1038/s41575-022-00611-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00611-z</ArticleId><ArticleId IdType="pmc">PMC8981882</ArticleId><ArticleId IdType="pubmed">35383321</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig RS, et al. The gut microbiome in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) Front. Immunol. 2022;12:628741. doi: 10.3389/fimmu.2021.628741.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.628741</ArticleId><ArticleId IdType="pmc">PMC8761622</ArticleId><ArticleId IdType="pubmed">35046929</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021;70:276&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385744</ArticleId><ArticleId IdType="pubmed">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163(495):506.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron, L. B. et al. Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-&#x3ba;B signaling. JCI Insight10.1172/jci.insight.160989 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9462470</ArticleId><ArticleId IdType="pubmed">35727635</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, et al. COVID-19 symptoms over time: comparing long-haulers to ME/CFS. Fatigue Biomed. Health Behav. 2021;9:59&#x2013;68. doi: 10.1080/21641846.2021.1922140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2021.1922140</ArticleId><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V-T, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat. Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A, Kelly C, Pottinger G, Hopkins C. Parosmia &#x2014; a common consequence of covid-19. BMJ. 2022;377:e069860. doi: 10.1136/bmj-2021-069860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069860</ArticleId><ArticleId IdType="pubmed">35477684</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal SM, et al. Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J. Am. Coll. Cardiol. 2022;79:2325&#x2013;2330. doi: 10.1016/j.jacc.2022.03.357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.03.357</ArticleId><ArticleId IdType="pmc">PMC8976261</ArticleId><ArticleId IdType="pubmed">35381331</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavileci B, &#xd6;zdemir E, &#xd6;zdemir B, Ereren E, Cengiz M. De-novo development of fragmented QRS during a six-month follow-up period in patients with COVID-19 disease and its cardiac effects. J. Electrocardiol. 2022;72:44&#x2013;48. doi: 10.1016/j.jelectrocard.2022.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2022.02.012</ArticleId><ArticleId IdType="pmc">PMC8917010</ArticleId><ArticleId IdType="pubmed">35306293</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist JT, et al. Lung abnormalities depicted with hyperpolarized 129Xe MRI in patients with long COVID. Radiology. 2022;305:709&#x2013;717. doi: 10.1148/radiol.220069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220069</ArticleId><ArticleId IdType="pmc">PMC9134268</ArticleId><ArticleId IdType="pubmed">35608443</ArticleId></ArticleIdList></Reference><Reference><Citation>US ME/CFS Clinician Coalition. Testing Recommendations for Suspected ME/CFS (US ME/CFS Clinician Coalition, 2021).</Citation></Reference><Reference><Citation>Gal&#xe1;n M, et al. Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with long-COVID: identification of diagnostic biomarkers. Front. Immunol. 2022;13:848886. doi: 10.3389/fimmu.2022.848886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandjean D, et al. Screening for SARS-CoV-2 persistence in Long COVID patients using sniffer dogs and scents from axillary sweats samples. Clin. Trials. 2022;12:2.</Citation></Reference><Reference><Citation>Pifarr&#xe9; F, et al. The use of oxygen as a possible screening biomarker for the diagnosis of chronic fatigue. Apunt. Sports Med. 2022;57:100379. doi: 10.1016/j.apunsm.2022.100379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apunsm.2022.100379</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Kalns J, Richarte A, Katz BZ, Torres C. Saliva fatigue biomarker index as a marker for severe myalgic encephalomyelitis/chronic fatigue syndrome in a community based sample. Fatigue Biomed. Health Behav. 2021;9:189&#x2013;195. doi: 10.1080/21641846.2021.1994222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2021.1994222</ArticleId><ArticleId IdType="pmc">PMC8855987</ArticleId><ArticleId IdType="pubmed">35186443</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandyarpour R, Kashi A, Nemat-Gorgani M, Wilhelmy J, Davis RW. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Proc. Natl Acad. Sci. USA. 2019;116:10250&#x2013;10257. doi: 10.1073/pnas.1901274116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1901274116</ArticleId><ArticleId IdType="pmc">PMC6535016</ArticleId><ArticleId IdType="pubmed">31036648</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkiliza A, et al. Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms. J. Transl Med. 2021;19:370. doi: 10.1186/s12967-021-03035-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03035-6</ArticleId><ArticleId IdType="pmc">PMC8401202</ArticleId><ArticleId IdType="pubmed">34454515</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton MJ, Chapman BP. &amp; Van Marwijk, H. Low-dose naltrexone as a treatment for chronic fatigue syndrome. BMJ Case Rep. 2020;13:e232502. doi: 10.1136/bcr-2019-232502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2019-232502</ArticleId><ArticleId IdType="pmc">PMC6954765</ArticleId><ArticleId IdType="pubmed">31911410</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitt B, Tate AM, Gluck D, Rosenson RS, Goonewardena SN. Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19. Eur. Heart J. Cardiovasc. Pharmacother. 2022 doi: 10.1093/ehjcvp/pvac014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcvp/pvac014</ArticleId><ArticleId IdType="pmc">PMC8903502</ArticleId><ArticleId IdType="pubmed">35179184</ArticleId></ArticleIdList></Reference><Reference><Citation>Alper K. Case report: famotidine for neuropsychiatric symptoms in COVID-19. Front. Med. 2020;7:614393. doi: 10.3389/fmed.2020.614393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.614393</ArticleId><ArticleId IdType="pmc">PMC7786260</ArticleId><ArticleId IdType="pubmed">33425958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, et al. Case report: neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Front. Med. 2021;8:754667. doi: 10.3389/fmed.2021.754667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, et al. Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front. Cell. Infect. Microbiol. 2022;12:861703. doi: 10.3389/fcimb.2022.861703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>The ME Association. A new treatment for Long Covid? The ME Associationhttps://meassociation.org.uk/2021/10/a-new-treatment-for-long-covid/ (2021).</Citation></Reference><Reference><Citation>T&#xf6;lle M, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: efficacy of repeat immunoadsorption. J. Clin. Med. 2020;9:E2443. doi: 10.3390/jcm9082443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082443</ArticleId><ArticleId IdType="pmc">PMC7465279</ArticleId><ArticleId IdType="pubmed">32751659</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 &#x2018;long-haulers&#x2019;? Chronic Dis. Transl Med. 2020;7:14&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. NICEhttps://www.nice.org.uk/guidance/NG206 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Support for Rehabilitation Self-Management After COVID-19 Related Illness (WHO, 2021).</Citation></Reference><Reference><Citation>CDC. Treatment of ME/CFS | Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). CDChttps://www.cdc.gov/me-cfs/treatment/index.html (2021).</Citation></Reference><Reference><Citation>Long COVID Physio. Exercise. Long COVID Physiohttps://longcovid.physio/exercise (2022).</Citation></Reference><Reference><Citation>Geng, L. N., Bonilla, H. F., Shafer, R. W., Miglis, M. G. &amp; Yang, P. C. Case report of breakthrough long COVID and the use of nirmatrelvir-ritonavir. Preprint at https://www.researchsquare.com/article/rs-1443341/v1 (2022).</Citation></Reference><Reference><Citation>Xie, Y., Choi, T. &amp; Al-Aly, Z. Nirmatrelvir and the risk of post-acute sequelae of COVID-19. Preprint at medRxiv10.1101/2022.11.03.22281783 (2022).</Citation></Reference><Reference><Citation>Charfeddine S, et al. Sulodexide in the treatment of patients with long COVID 19 symptoms and endothelial dysfunction: the results of TUN-EndCOV study. Arch. Cardiovasc. Dis. Suppl. 2022;14:127.</Citation></Reference><Reference><Citation>Thomas R, et al. A randomised, double-blind, placebo-controlled trial evaluating concentrated phytochemical-rich nutritional capsule in addition to a probiotic capsule on clinical outcomes among individuals with COVID-19 &#x2014; the UK Phyto-V study. COVID. 2022;2:433&#x2013;449. doi: 10.3390/covid2040031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid2040031</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, et al. Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: an open-label pilot study. J. Gastroenterol. Hepatol. 2022;37:823&#x2013;831. doi: 10.1111/jgh.15796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15796</ArticleId><ArticleId IdType="pmc">PMC9115073</ArticleId><ArticleId IdType="pubmed">35170078</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu LD, Duricka DL. Stellate ganglion block reduces symptoms of Long COVID: a case series. J. Neuroimmunol. 2022;362:577784. doi: 10.1016/j.jneuroim.2021.577784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577784</ArticleId><ArticleId IdType="pmc">PMC8653406</ArticleId><ArticleId IdType="pubmed">34922127</ArticleId></ArticleIdList></Reference><Reference><Citation>Belcaro G, et al. Preventive effects of Pycnogenol&#xae; on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19) Minerva Med. 2022;113:300&#x2013;308. doi: 10.23736/S0026-4806.21.07650-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0026-4806.21.07650-3</ArticleId><ArticleId IdType="pubmed">34060731</ArticleId></ArticleIdList></Reference><Reference><Citation>Crooks V, Waller S, Smith T, Hahn TJ. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J. Gerontol. 1991;46:M139&#x2013;M144. doi: 10.1093/geronj/46.4.M139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/46.4.M139</ArticleId><ArticleId IdType="pubmed">2071835</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Long-COVID treatments: why the world is still waiting. Nature. 2022;608:258&#x2013;260. doi: 10.1038/d41586-022-02140-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-02140-w</ArticleId><ArticleId IdType="pubmed">35945375</ArticleId></ArticleIdList></Reference><Reference><Citation>Toogood PL, Clauw DJ, Phadke S, Hoffman D. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): where will the drugs come from? Pharmacol. Res. 2021;165:105465. doi: 10.1016/j.phrs.2021.105465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105465</ArticleId><ArticleId IdType="pubmed">33529750</ArticleId></ArticleIdList></Reference><Reference><Citation>US ME/CFS Clinician Coalition. ME/CFS Treatment Recommendations (US ME/CFS Clinician Coalition, 2021).</Citation></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Self-reported long COVID after infection with the Omicron variant in the UK: 6 May 2022. Office for National Statisticshttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/6may2022 (2022).</Citation></Reference><Reference><Citation>Tsuchida T, et al. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID. J. Med. Virol. 2022;94:3416&#x2013;3420. doi: 10.1002/jmv.27689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27689</ArticleId><ArticleId IdType="pmc">PMC9088489</ArticleId><ArticleId IdType="pubmed">35238053</ArticleId></ArticleIdList></Reference><Reference><Citation>VA COVID-19 Observational Research Collaboratory. Burden of PCR-confirmed SARS-CoV-2 reinfection in the U.S. Veterans Administration, March 2020 &#x2013; January 2022. Preprint at medRxiv10.1101/2022.03.20.22272571 (2022).</Citation></Reference><Reference><Citation>Bowe, B., Xie, Y. &amp; Al-Aly, Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 10.1038/s41591-022-02051-3 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg J, Gottfries C-G, Elfaitouri A, Rizwan M, Ros&#xe9;n A. Infection elicited autoimmunity and myalgic encephalomyelitis/chronic fatigue syndrome: an explanatory model. Front. Immunol. 2018;9:229. doi: 10.3389/fimmu.2018.00229.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00229</ArticleId><ArticleId IdType="pmc">PMC5818468</ArticleId><ArticleId IdType="pubmed">29497420</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauchemez S, Bosetti P. A reconstruction of early cryptic COVID spread. Nature. 2021;600:40&#x2013;41. doi: 10.1038/d41586-021-02989-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-02989-3</ArticleId><ArticleId IdType="pubmed">34725517</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Estimated COVID-19 burden. Centers for Disease Control and Preventionhttps://www.cdc.gov/coronavirus/2019-ncov/cases-updates/burden.html (2020).</Citation></Reference><Reference><Citation>Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction&#x2013;based SARS-CoV-2 tests by time since exposure. Ann. Intern. Med. 2020;173:262&#x2013;267. doi: 10.7326/M20-1495.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-1495</ArticleId><ArticleId IdType="pmc">PMC7240870</ArticleId><ArticleId IdType="pubmed">32422057</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine-Tiefenbrun M, et al. SARS-CoV-2 RT-qPCR test detection rates are associated with patient age, sex, and time since diagnosis. J. Mol. Diagn. 2022;24:112&#x2013;119. doi: 10.1016/j.jmoldx.2021.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmoldx.2021.10.010</ArticleId><ArticleId IdType="pmc">PMC8608683</ArticleId><ArticleId IdType="pubmed">34826637</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarvis KF, Kelley JB. Temporal dynamics of viral load and false negative rate influence the levels of testing necessary to combat COVID-19 spread. Sci. Rep. 2021;11:9221. doi: 10.1038/s41598-021-88498-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88498-9</ArticleId><ArticleId IdType="pmc">PMC8080800</ArticleId><ArticleId IdType="pubmed">33911131</ArticleId></ArticleIdList></Reference><Reference><Citation>Dattner I, et al. The role of children in the spread of COVID-19: using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children. PLoS Comput. Biol. 2021;17:e1008559. doi: 10.1371/journal.pcbi.1008559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1008559</ArticleId><ArticleId IdType="pmc">PMC7877572</ArticleId><ArticleId IdType="pubmed">33571188</ArticleId></ArticleIdList></Reference><Reference><Citation>Langeland N, Cox RJ. Are low SARS-CoV-2 viral loads in infected children missed by RT-PCR testing? Lancet Reg. Health Eur. 2021;5:100138. doi: 10.1016/j.lanepe.2021.100138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100138</ArticleId><ArticleId IdType="pmc">PMC8159172</ArticleId><ArticleId IdType="pubmed">34075368</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Elslande J, et al. Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. J. Clin. Virol. 2021;136:104765. doi: 10.1016/j.jcv.2021.104765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2021.104765</ArticleId><ArticleId IdType="pmc">PMC7891078</ArticleId><ArticleId IdType="pubmed">33636554</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, et al. Predictors of nonseroconversion after SARS-CoV-2 infection. Emerg. Infect. Dis. 2021;27:2454&#x2013;2458. doi: 10.3201/eid2709.211042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2709.211042</ArticleId><ArticleId IdType="pmc">PMC8386781</ArticleId><ArticleId IdType="pubmed">34193339</ArticleId></ArticleIdList></Reference><Reference><Citation>Toh ZQ, et al. Comparison of seroconversion in children and adults with mild COVID-19. JAMA Netw. Open. 2022;5:e221313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8908077</ArticleId><ArticleId IdType="pubmed">35262717</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson TM, et al. Coverage of CFS within U.S. medical schools. Univers. J. Public Health. 2013;1:177&#x2013;179. doi: 10.13189/ujph.2013.010404.</Citation><ArticleIdList><ArticleId IdType="doi">10.13189/ujph.2013.010404</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, et al. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J. Pediatr. 1999;135:494&#x2013;499. doi: 10.1016/S0022-3476(99)70173-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(99)70173-3</ArticleId><ArticleId IdType="pubmed">10518084</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T, et al. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients. Asian Pac. J. Allergy Immunol. 2017;35:75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">27362406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner C, Isenmann S, Ringendahl H, Haensch C-A. Anxiety in patients with postural tachycardia syndrome (POTS) Fortschr. Neurol. Psychiatr. 2012;80:458&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">22692879</ArticleId></ArticleIdList></Reference><Reference><Citation>Grayson DA, Mackinnon A, Jorm AF, Creasey H, Broe GA. Item bias in the center for epidemiologic studies depression scale: effects of physical disorders and disability in an elderly community sample. J. Gerontol. Ser. B. 2000;55:P273&#x2013;P282. doi: 10.1093/geronb/55.5.P273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/55.5.P273</ArticleId><ArticleId IdType="pubmed">10985292</ArticleId></ArticleIdList></Reference><Reference><Citation>Twisk FNM, Maes M. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Neuro Endocrinol. Lett. 2009;30:284&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">19855350</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M, Vink-Niese F. Is it useful to question the recovery behaviour of patients with ME/CFS or Long COVID? Healthcare. 2022;10:392. doi: 10.3390/healthcare10020392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10020392</ArticleId><ArticleId IdType="pmc">PMC8872229</ArticleId><ArticleId IdType="pubmed">35207003</ArticleId></ArticleIdList></Reference><Reference><Citation>Dysautonomia International. What is dysautonomia? Dysautonomia Internationalhttp://www.dysautonomiainternational.org/page.php?ID=34 (2022).</Citation></Reference><Reference><Citation>CDC. Epidemiology | Presentation and clinical course | Healthcare providers | Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). CDChttps://www.cdc.gov/me-cfs/healthcare-providers/presentation-clinical-course/epidemiology.html (2021).</Citation></Reference><Reference><Citation>S&#xf8;rensen AIV, et al. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark. Nat. Commun. 2022;13:4213. doi: 10.1038/s41467-022-31897-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31897-x</ArticleId><ArticleId IdType="pmc">PMC9302226</ArticleId><ArticleId IdType="pubmed">35864108</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg SK, et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0&#x2013;14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc. Health. 2022;6:614&#x2013;623. doi: 10.1016/S2352-4642(22)00154-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00154-7</ArticleId><ArticleId IdType="pmc">PMC9221683</ArticleId><ArticleId IdType="pubmed">35752194</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow AK, et al. Long-term COVID 19 sequelae in adolescents: the overlap with orthostatic intolerance and ME/CFS. Curr. Pediatr. Rep. 2022;10:31&#x2013;44. doi: 10.1007/s40124-022-00261-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40124-022-00261-4</ArticleId><ArticleId IdType="pmc">PMC8906524</ArticleId><ArticleId IdType="pubmed">35287333</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper S, et al. Long COVID-19 liver manifestation in children. J. Pediatr. Gastroenterol. Nutr. 2022 doi: 10.1097/MPG.0000000000003521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0000000000003521</ArticleId><ArticleId IdType="pubmed">35687535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L. Post&#x2013;COVID-19 symptoms and conditions among children and adolescents &#x2014; United States, March 1, 2020&#x2013;January 31, 2022. MMWR Morb. Mortal. Wkly Rep. 2022;71:993&#x2013;999. doi: 10.15585/mmwr.mm7131a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7131a3</ArticleId><ArticleId IdType="pmc">PMC9368731</ArticleId><ArticleId IdType="pubmed">35925799</ArticleId></ArticleIdList></Reference><Reference><Citation>Edlow AG, Castro VM, Shook LL, Kaimal AJ, Perlis RH. Neurodevelopmental outcomes at 1 year in infants of mothers who tested positive for SARS-CoV-2 during pregnancy. JAMA Netw. Open. 2022;5:e2215787. doi: 10.1001/jamanetworkopen.2022.15787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.15787</ArticleId><ArticleId IdType="pmc">PMC9185175</ArticleId><ArticleId IdType="pubmed">35679048</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand A, et al. Similar patterns of [18F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series. Eur. J. Nucl. Med. Mol. Imaging. 2022;49:913&#x2013;920. doi: 10.1007/s00259-021-05528-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05528-4</ArticleId><ArticleId IdType="pmc">PMC8376118</ArticleId><ArticleId IdType="pubmed">34414470</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss R, et al. Pulmonary dysfunction after pediatric COVID-19. Radiology. 2022 doi: 10.1148/radiol.221250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.221250</ArticleId><ArticleId IdType="pmc">PMC9513839</ArticleId><ArticleId IdType="pubmed">36125379</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>